Mitchell & Pahl Private Wealth LLC Increases Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Mitchell & Pahl Private Wealth LLC grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 1.8% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 8,675 shares of the medical device company’s stock after acquiring an additional 157 shares during the quarter. Mitchell & Pahl Private Wealth LLC’s holdings in Cooper Companies were worth $732,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Czech National Bank boosted its holdings in Cooper Companies by 6.2% in the first quarter. Czech National Bank now owns 45,841 shares of the medical device company’s stock valued at $3,867,000 after purchasing an additional 2,660 shares in the last quarter. Mirador Capital Partners LP lifted its position in shares of Cooper Companies by 7.9% during the 1st quarter. Mirador Capital Partners LP now owns 14,421 shares of the medical device company’s stock worth $1,216,000 after buying an additional 1,061 shares during the last quarter. Rhumbline Advisers boosted its holdings in shares of Cooper Companies by 9.6% in the 1st quarter. Rhumbline Advisers now owns 388,960 shares of the medical device company’s stock valued at $32,809,000 after buying an additional 34,060 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Cooper Companies by 5,733.1% in the 1st quarter. GAMMA Investing LLC now owns 210,285 shares of the medical device company’s stock valued at $17,738,000 after buying an additional 206,680 shares during the last quarter. Finally, Wellington Management Group LLP raised its stake in Cooper Companies by 517.1% during the 4th quarter. Wellington Management Group LLP now owns 175,152 shares of the medical device company’s stock worth $16,102,000 after acquiring an additional 146,771 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $68.94 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market cap of $13.79 billion, a PE ratio of 35.35, a P/E/G ratio of 2.25 and a beta of 1.08. The stock has a fifty day moving average price of $79.82 and a 200 day moving average price of $88.29. The Cooper Companies, Inc. has a 1-year low of $65.95 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.93 by $0.03. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same period in the prior year, the business posted $0.85 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

COO has been the subject of several research analyst reports. Piper Sandler restated an “overweight” rating and issued a $105.00 price objective (down previously from $115.00) on shares of Cooper Companies in a research note on Friday. BNP Paribas raised Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Robert W. Baird reduced their price objective on Cooper Companies from $107.00 to $97.00 and set an “outperform” rating for the company in a research note on Friday. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a report on Friday. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $100.38.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.